Creso Pharma


Blueberries Medical Corp.

CNSX: BBM


Canadian symbol: BBM.CN
US symbol: BBRRF

Currency in CAD

Valuation Measures

Market Cap (intraday) 512.04M
Enterprise Value 316.92M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)182.43
Price/Book (mrq)3.06
Enterprise Value/Revenue 3256.38
Enterprise Value/EBITDA 7-4.74

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 326.67%
S&P500 52-Week Change 339.22%
52 Week High 30.2500
52 Week Low 30.0350
50-Day Moving Average 30.1360
200-Day Moving Average 30.1233

Share Statistics

Avg Vol (3 month) 3172.79k
Avg Vol (10 day) 367.21k
Shares Outstanding 5126.7M
Implied Shares Outstanding 6N/A
Float 121.41M
% Held by Insiders 15.20%
% Held by Institutions 12.81%
Shares Short (Apr. 14, 2021) 4341.89k
Short Ratio (Apr. 14, 2021) 42.49
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.28%
Shares Short (prior month Mar. 14, 2021) 4126.35k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul. 03, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,251.54%

Management Effectiveness

Return on Assets (ttm)-30.23%
Return on Equity (ttm)-82.57%

Income Statement

Revenue (ttm)65.98k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)62.4k
EBITDA -3.57M
Net Income Avi to Common (ttm)-4.94M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)306.51k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.49M
Total Debt/Equity (mrq)38.36
Current Ratio (mrq)0.25
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-2.39M
Levered Free Cash Flow (ttm)-992.95k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
BBM.CN
Blueberries Medical
3 months ago
BBM.CN
Blueberries Medical
10 months ago
BBM.CN
Blueberries Medical
11 months ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
1 year ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago
BBM.CN
Blueberries Medical
2 years ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
5.20%% of Shares Held by All Insider
2.81%% of Shares Held by Institutions
2.96%% of Float Held by Institutions
1Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Blueberries Medical Corp.


Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay

TORONTO, March 26, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or “Blueberries”), today announced that it has signed a Framewor... Read More...
Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms

Blueberries Medical Enters Growing Peruvian Medical Cannabis Market: Enters Binding LOI with Futura Farms

TORONTO, March 15, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS will supply premium, formulated cannabis oil to Futura Farms, a licens... Read More...
Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

Blueberries Medical Appoints Former Clever Leaves Global Head of B2B as President of Latin American Operations

TORONTO, Feb. 10, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of José María Forero, the former Global Head of B2B of Clever Leaves Holdings Inc. (NASDAQ: ... Read More...
Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

TORONTO, Jan. 20, 2021 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private placement for aggregate gross proceeds of C$1,000,000 (the “Offerin... Read More...
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

TORONTO, Dec. 04, 2020 -- Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce that the Company has completed the ac... Read More...
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

TORONTO, Oct. 26, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products announced today that the Company received approval from the Colombian Agricultural Institute (“ICA”) for the registration of its nin... Read More...
Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

TORONTO, July 24, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the Annual General and Special Meeting of the shareholders of Blueberri... Read More...
Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

TORONTO, July 16, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed a non-brokered private placement offering (the “Offering”) of C$1,000,000 in principal amount ... Read More...
Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 -- Blueberries Medical Corp. (CSE:BBM) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agricultur... Read More...
Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

TORONTO, May 05, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a Joint Venture (the “JV”) with QualCann SAS (“QualCann”), an arm’s length ... Read More...
Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

TORONTO, April 23, 2020 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Ministry of Justice and Law of the Republic of Colombia has granted a non-psychoactive cultivation... Read More...
Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

TORONTO, Dec. 16, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed Mr. Camilo Villalba as Chief Executive Officer of the Company. Mr.... Read More...
Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

TORONTO, Dec. 03, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced harvest of its first commercial crops at its 3.2-hectare Guatavita facility located in Bogotá Sa... Read More...
Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

TORONTO, Oct. 31, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with the Van Uden International Center for Alternative Medicine (“Van... Read More...
Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

TORONTO, Sept. 27, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval from the Colombian Institute of Agriculture (“ICA”) for the registra... Read More...
Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

Blueberries Medical and The Colombian Society of Pediatrics Partner to Host Medicinal Cannabis Seminar in Bogota

TORONTO, Sept. 18, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with The Colombian Society of Pediatrics to host a full-day educational semi... Read More...
Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

Blueberries Medical Announces Internationally Renowned Medical & Scientific Committee

TORONTO, Sept. 12, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the formation of its medical & scientific committee to support management in the development of... Read More...
Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Blueberries Medical Corp. Closes Over-Subscribed Private Placement

Not for distribution into the United States or to U.S. newswire servicesTORONTO, Aug. 30, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed its over-subsc... Read More...
Blueberries Medical Announces $3 Million Non-Brokered Private Placement

Blueberries Medical Announces $3 Million Non-Brokered Private Placement

TORONTO, Aug. 12, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement of up to 12,000,000 units (the “Units”) at a price of C$0.25 per Unit for gross ... Read More...
Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update

Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update

TORONTO, July 18, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide investors with the following update on the Company’s significant recent operational achievements and upcoming m... Read More...
Blueberries Announces DTC Eligibility of its Common Shares in the United States

Blueberries Announces DTC Eligibility of its Common Shares in the United States

TORONTO, July 04, 2019 -- Blueberries Medical Corp. (CSE: BBM) (BBRRF) (1OA.F) ("Blueberries" or the "Company"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s common shares, traded in the United States under the symbol BBRRF, are now eligible for e... Read More...
Blueberries Executes Definitive Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Property in Argentina

Blueberries Executes Definitive Agreement to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2M Square Foot Property in Argentina

TORONTO, July 02, 2019 -- Further to its news releases dated March 26 and April 4, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a d... Read More...
Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina

TORONTO, June 11, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products and SLANG Worldwide Inc. (CSE: SLNG), (Frankfurt: 84S), (“SLANG”) a leading global cannabis consumer packaged goods (“CPG”) company with a ... Read More...
Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

Blueberries Announces Cannabis Sales and Distribution Agreement for German Market

TORONTO, June 05, 2019 -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has entered into a letter agreement (the "Letter Agreement") to become a strategic supplie... Read More...
Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator

TORONTO, May 13, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has received approval for the production, sale and export of five cannabidiol ("CBD") based he... Read More...
Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

Blueberries Medical Appoints Former Abbott Laboratories/AbbVie Pharmaceutical Executive Eduardo Molinari as Chief Marketing Officer

Strategic Hire Adds Further Latin American and International Pharmaceutical Industry Experience to Management TeamTORONTO, April 17, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the ... Read More...
Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

Blueberries Medical to Collaborate with the International Research Center on Cannabis and Mental Health in New York for Product Formulation and the Development of Treatment-Focused Medical Education Programs

TORONTO, April 15, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licenced producer of medicinal cannabis and cannabis-derived products, has signed a definitive joint venture agreement (the “Agreement”) with the International Research Center on Cannabis and Mental Health (“IRCC... Read More...
Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

TORONTO, April 12, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries") a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s executive management team will attend and present at GMP Securities’ 2019 Global Cannabis Conferenc... Read More...
Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

Blueberries Medical Commences Formal Development Process for the Cultivation of Cannabis in Jujuy Argentina

TORONTO, April 04, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a Latin American focused licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced the Phase 1 planning process with Argentinian state owned cannabis company Cannabis Ava... Read More...
Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

Blueberries Medical Commences Trading in the United States on OTCQB Market Under Symbol BBRRF

TORONTO, April 01, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that its common shares will commences trading on the OTCQB Market (the “OTCQB”) today under the ticker symbol... Read More...
Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina

TORONTO, March 26, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia based licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a binding agreement effective March 25, 2019  to acquire cannabis cultivati... Read More...
FinancialBuzz.com Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City

FinancialBuzz.com Exclusive Interview With Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. Live on Wall Street in New York City

NEW YORK, March 22, 2019 -- FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Chief Operating Officer, Camilo Villalba of Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 10A) live on Wall Street.   Mr. Villalba shares with us his backgr... Read More...
Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer

Blueberries Medical Appoints Former PharmaCielo CEO Dr. Patricio Stocker as Chief Executive Officer

Appointment Adds Extensive Strategic Expertise in the Latin American and International Cannabis Industries and Related Capital MarketsTORONTO, March 20, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products... Read More...
Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors

Blueberries Medical Appoints Former Colombian Minister & Ambassador Fabio Valencia to Board of Directors

Appointment Adds Extensive International Commercial Expertise and Further Expands Strategic Relationships within South America and the European UnionTORONTO, March 19, 2019 -- Blueberries Medical Corp. (BBM.CN) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-d... Read More...
Blueberries Medical Lists on Frankfurt Stock Exchange Under Symbol 1OA

Blueberries Medical Lists on Frankfurt Stock Exchange Under Symbol 1OA

TORONTO, March 04, 2019 -- Blueberries Medical Corp. (CSE:BBM) (BBRRF) (1OA.F) (the “Company” or "Blueberries"), a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, announces today that its common shares are now listed on the Frankfurt Stock Exchange (FSE) trading under the ticker symbol “1OA”. ... Read More...
Blueberries Medical Enters into Agreement with a Leading Colombian Craft Brewer to Pioneer the Development and Commercialization of Cannabis Based Beverages in Latin America

Blueberries Medical Enters into Agreement with a Leading Colombian Craft Brewer to Pioneer the Development and Commercialization of Cannabis Based Beverages in Latin America

TORONTO, Feb. 25, 2019 -- Blueberries Medical Corp. (CSE:BBM) (the “Company” or "Blueberries") a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, announces today that it has entered into a letter of intent (the “Agreement”) for a joint venture (the “Joint Venture”) with India Colorada S.A.S., (... Read More...
Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity

Blueberries Medical Acquires an Additional 37 Acres of Prime Agricultural Land to Significantly Increase Cannabis Production Capacity

TORONTO, Feb. 20, 2019 -- Blueberries Medical Corp. (CSE:BBM) (the “Company” or "Blueberries") a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products is pleased to announce that it has completed the acquisition of a 37-acre (15 hectare) agricultural property in the Bogota Savannah (the "Zipaquira Pr... Read More...
Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV

Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV

TORONTO, Feb. 14, 2019 -- Blueberries Medical Corp. (CSE:BBM) (the “Company” or "Blueberries"), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products, has entered into a letter of intent (the “Letter Agreement”) dated February 13, 2019 for a joint venture (the “Joint Venture”) with Harmony and Life... Read More...
Coming Soon.

Delayed data (1h)


Share this page